BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simón-talero M, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-martinez R, Dam A, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Bañares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genescà J, Quiroga S, Yu D, Téllez L, Mandorfer M, Garcia-pagan JC, Berbel C, Ferrusquia J, Ble M, Garcia-criado MA, Belmonte E, Ney M, Margini C, Casu S, Murgia G, Ludwig C, Rönsch M, Stoevesandt D, Carrion L, Botella ER. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Gastroenterology 2018;154:1694-1705.e4. [DOI: 10.1053/j.gastro.2018.01.028] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Patil NS, Pamecha V, Sinha PK, Dangi DS, Mohapatra N. Clinical Outcomes of Portosystemic Shunts on the Outcome of Liver Transplantation. Liver Transpl 2021;27:144-5. [PMID: 32735756 DOI: 10.1002/lt.25856] [Reference Citation Analysis]
2 Hidaka H, Uojima H. Ultrasonography in the diagnosis of complications in patients with portal hypertension. J Med Ultrason (2001) 2021. [PMID: 34787743 DOI: 10.1007/s10396-021-01158-3] [Reference Citation Analysis]
3 Nardelli S, Riggio O, Gioia S, Puzzono M, Pelle G, Ridola L. Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects. World J Gastroenterol 2020; 26(15): 1726-1732 [PMID: 32351289 DOI: 10.3748/wjg.v26.i15.1726] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
4 Greinert R, Zipprich A, Simón-Talero M, Stangl F, Ludwig C, Wienke A, Praktiknjo M, Höhne K, Trebicka J, Genescà J, Ripoll C. Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy. Liver Int 2020;40:3093-102. [PMID: 32890428 DOI: 10.1111/liv.14660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Xu H, Cheng B, Wang R, Ding M, Gao Y. Portopulmonary hypertension: Current developments and future perspectives. Liver Research 2022. [DOI: 10.1016/j.livres.2022.02.002] [Reference Citation Analysis]
6 Philips CA, Rajesh S, Augustine P, Padsalgi G, Ahamed R. Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options. Hepat Med. 2019;11:23-34. [PMID: 30774483 DOI: 10.2147/hmer.s169024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 5.3] [Reference Citation Analysis]
7 Guillaume M, Bureau C. Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome? Gastroenterology 2018;154:1569-71. [DOI: 10.1053/j.gastro.2018.03.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
8 Piecha F, Radunski UK, Ozga AK, Steins D, Drolz A, Horvatits T, Spink C, Ittrich H, Benten D, Lohse AW, Sinning C, Kluwe J. Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival. JHEP Rep. 2019;1:90-98. [PMID: 32039356 DOI: 10.1016/j.jhepr.2019.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
9 Dajti E, Renzulli M, Colecchia A, Bacchi-Reggiani ML, Milandri M, Rossini B, Ravaioli F, Marasco G, Alemanni LV, Ierardi AM, Carrafiello G, Pinzani M, Azzaroli F, Mazzella G, Golfieri R, Festi D. Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients. Dig Liver Dis 2022;54:103-10. [PMID: 33414086 DOI: 10.1016/j.dld.2020.12.114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Vidal-González J, Simón-Talero M, Genescà J. Should prophylactic embolization of spontaneous portosystemic shunts be routinely performed during transjugular intrahepatic portosystemic shunt placement? Dig Liver Dis 2018;50:1324-6. [PMID: 30005961 DOI: 10.1016/j.dld.2018.06.013] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Philips CA, Rajesh S, George T, Ahamed R, Mohanan M, Augustine P. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy. Indian J Gastroenterol 2020;39:377-87. [PMID: 32929684 DOI: 10.1007/s12664-020-01042-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chao CT, Wang J, Huang JW, Chien KL. Acarbose Use and Liver Injury in Diabetic Patients With Severe Renal Insufficiency and Hepatic Diseases: A Propensity Score-Matched Cohort Study. Front Pharmacol. 2018;9:860. [PMID: 30131698 DOI: 10.3389/fphar.2018.00860] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
13 Sauerbruch T, Hennenberg M, Trebicka J, Beuers U. Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction. Front Physiol 2021;12:718783. [PMID: 34393832 DOI: 10.3389/fphys.2021.718783] [Reference Citation Analysis]
14 Rathi S, Brocco S, Formentin C, Zarantonello L, Mangini C, Meneghello G, Merkel C, Angeli P, Stramare R, Montagnese S, Amodio P. Spontaneous portosystemic shunts in cirrhosis: Detection, implications, and clinical associations. Dig Liver Dis 2021;53:1468-75. [PMID: 33341422 DOI: 10.1016/j.dld.2020.11.020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Bauer D, Kozbial K, Schwabl P, Chromy D, Simbrunner B, Stättermayer AF, Pinter M, Steindl-munda P, Trauner M, Ferenci P, Reiberger T, Mandorfer M. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.02.013] [Reference Citation Analysis]
16 Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O. Hepatic Encephalopathy: Diagnosis and Management. J Transl Int Med 2020;8:210-9. [PMID: 33511048 DOI: 10.2478/jtim-2020-0034] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Privitera G, Figorilli F, Jalan R, Mehta G. Portosystemic Shunt Embolization and Recurrent Ascites: A Single-Center Case Series. Gastroenterology 2018;155:1649-50. [DOI: 10.1053/j.gastro.2018.06.092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Schwabl P, Seeland BA, Riedl F, Schubert TL, Königshofer P, Brusilovskaya K, Petrenko O, Hofer B, Schiefer AI, Trauner M, Peck-Radosavljevic M, Reiberger T. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension. Adv Med Sci 2022;67:154-62. [PMID: 35272246 DOI: 10.1016/j.advms.2022.02.005] [Reference Citation Analysis]
19 Premkumar M, Dhiman RK. UPDATE IN HEPATIC ENCEPHALOPATHY - PART II. J Clin Exp Hepatol 2018;8:333-4. [PMID: 30568343 DOI: 10.1016/j.jceh.2018.11.001] [Reference Citation Analysis]
20 Jachs M, Reiberger T. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach. Clin Liver Dis 2021;25:311-26. [PMID: 33838852 DOI: 10.1016/j.cld.2021.01.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Magaz M, Baiges A, Hernández-Gea V. Precision medicine in variceal bleeding: Are we there yet? J Hepatol. 2020;72:774-784. [PMID: 31981725 DOI: 10.1016/j.jhep.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
22 Liu L, Nie Y, Zhang Y, Liu Q, Zhu X. Liver Stiffness Is a Predictor of Rebleeding in Patients With Hepatitis B-Related Cirrhosis: A Real-World Cohort Study. Front Med (Lausanne) 2021;8:690825. [PMID: 34395474 DOI: 10.3389/fmed.2021.690825] [Reference Citation Analysis]
23 Karagiannakis DS, Voulgaris T, Siakavellas SI, Papatheodoridis GV, Vlachogiannakos J. Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond. Scand J Gastroenterol 2018;53:1153-64. [PMID: 30345856 DOI: 10.1080/00365521.2018.1506046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Ridola L, Riggio O, Gioia S, Faccioli J, Nardelli S. Clinical management of type C hepatic encephalopathy. United European Gastroenterol J 2020;8:536-43. [PMID: 32213035 DOI: 10.1177/2050640620909675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
25 Li X, Partovi S, Coronado WM, Gadani S, Martin C, Thompson D, Levitin A, Kapoor B. Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management. Cardiovasc Intervent Radiol 2022. [PMID: 34981195 DOI: 10.1007/s00270-021-03045-3] [Reference Citation Analysis]
26 Li Y, Liu Z, Liu C. Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt. BMC Gastroenterol 2021;21:61. [PMID: 33573590 DOI: 10.1186/s12876-021-01647-2] [Reference Citation Analysis]
27 Ebel NH, Carlin K, Shaffer ML, Shivaram G, Hawkins M, Lane ER, Cooper K, Lindquester WS, Gadodia G, Murray KF. Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension. J Pediatr Gastroenterol Nutr 2019;68:788-92. [PMID: 30921261 DOI: 10.1097/MPG.0000000000002327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
28 Rodriguez EA, Perez R, Zhang N, Lim ES, Miller C, Schwartz MA, McGirr AJ, Srinivasan A, Hewitt W, Silva AC, Rakela J, Vargas HE. Clinical Outcomes of Portosystemic Shunts on the Short-Term Outcome of Liver Transplantation. Liver Transpl. 2019;. [PMID: 31872966 DOI: 10.1002/lt.25710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
29 Liu GF, Wang XZ, Luo XF. Simultaneous embolization of a spontaneous porto-systemic shunt and intrahepatic arterioportal fistula: A case report. World J Clin Cases 2021; 9(31): 9577-9583 [PMID: 34877293 DOI: 10.12998/wjcc.v9.i31.9577] [Reference Citation Analysis]
30 Zhang H, Xiao J, Tu J, Zhang M, Zhang F, Yin Q, Zhuge Y. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment. Eur J Gastroenterol Hepatol 2021;33:752-61. [PMID: 33731589 DOI: 10.1097/MEG.0000000000002079] [Reference Citation Analysis]
31 Yi F, Guo X, Wang L, Xu X, An Y, Tang Y, Zhang W, Tacke F, Arora A, Qi X. Impact of spontaneous splenorenal shunt on liver volume and long-term survival of liver cirrhosis. J Gastroenterol Hepatol 2021;36:1694-702. [PMID: 33393106 DOI: 10.1111/jgh.15386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
32 Vozzo CF, Singh T, Bullen J, Sarvepalli S, McCullough A, Kapoor B. Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience. Gastroenterol Rep (Oxf) 2020;8:98-103. [PMID: 32280469 DOI: 10.1093/gastro/goz062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Vuille-Lessard É, Rodrigues SG, Berzigotti A. Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:253-89. [PMID: 33838850 DOI: 10.1016/j.cld.2021.01.005] [Reference Citation Analysis]
34 Rajesh S, Philips CA, Ahamed R, Abduljaleel JK, Nair DC, Augustine P. Friend or Foe? Spontaneous Portosystemic Shunts in Cirrhosis-Current Understanding and Future Prospects. Can J Gastroenterol Hepatol 2021;2021:8795115. [PMID: 34422711 DOI: 10.1155/2021/8795115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, Marchesini G, Merli M, Ponziani FR, Riggio O, Scarpignato C. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019;51:190-205. [PMID: 30606696 DOI: 10.1016/j.dld.2018.11.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
36 Nardelli S, Riggio O, Gioia S, Merli M, Spagnoli A, di Martino M, Pelle G, Ridola L. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2021.12.015] [Reference Citation Analysis]
37 Patricia Á, Campos-varela I, Quiroga S, Díez I, Charco R, Simón-talero M, Castells L. Spontaneous Portosystemic Shunt Embolization in Liver Transplant Recipients with Recurrent Hepatic Encephalopathy. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100687] [Reference Citation Analysis]
38 Nishida S, Hamada K, Nishino N, Fukushima D, Koyanagi R, Horikawa Y, Shiwa Y, Saitoh S. Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese. World J Hepatol 2019; 11(6): 531-541 [PMID: 31293721 DOI: 10.4254/wjh.v11.i6.531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
39 García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. [PMID: 32671331 DOI: 10.1016/j.jhepr.2020.100122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
40 Tatsumi A, Maekawa S, Osawa L, Katoh R, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Muraoka M, Suzuki Y, Sato M, Takahashi E, Miura M, Amemiya F, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Okada H, Araki T, Onishi H, Enomoto N. Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration. JGH Open. [DOI: 10.1002/jgh3.12712] [Reference Citation Analysis]
41 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
42 Wang X, Luo X, Yang L. Achieving an effective pressure reduction after TIPS: The need for a new target. Journal of Hepatology 2021;75:246-8. [DOI: 10.1016/j.jhep.2021.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Renzulli M, Dajti E, Ierardi AM, Brandi N, Berzigotti A, Milandri M, Rossini B, Clemente A, Ravaioli F, Marasco G, Azzaroli F, Carrafiello G, Festi D, Colecchia A, Golfieri R. Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients. Eur J Radiol 2021;:110010. [PMID: 34801322 DOI: 10.1016/j.ejrad.2021.110010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. J Hepatol 2021;75 Suppl 1:S36-48. [PMID: 34039491 DOI: 10.1016/j.jhep.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Bhangui P, Lim C, Levesque E, Salloum C, Lahat E, Feray C, Azoulay D. Novel classification of non-malignant portal vein thrombosis: A guide to surgical decision-making during liver transplantation. J Hepatol. 2019;71:1038-1050. [PMID: 31442476 DOI: 10.1016/j.jhep.2019.08.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
46 Praktiknjo M, Torner J, Simón-Talero M, Gu W, Perez-Poch A, Torre C, Val ID, Alpiste F, Genescà J, Trebicka J. Reply to: "Definition of SPSS: we need to speak the same language": Computer-assisted image processing for better quantification. J Hepatol 2020;73:464-5. [PMID: 32471728 DOI: 10.1016/j.jhep.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
47 Kaczmarek DJ, Kupczyk P, Schultheiß M, Chang J, Jansen C, Trebicka J, Weismüller T, Vilz TO, Luu AM, Attenberger U, Strassburg CP, Meyer C, Praktiknjo M. TIPS for the management of stomal variceal bleeding due to cirrhotic and non-cirrhotic portal hypertension. Z Gastroenterol 2021. [PMID: 34741298 DOI: 10.1055/a-1508-6446] [Reference Citation Analysis]
48 Schindler P, Heinzow H, Trebicka J, Wildgruber M. Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges. J Clin Med 2020;9:E3784. [PMID: 33238576 DOI: 10.3390/jcm9113784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Nardelli S, Riggio O, Turco L, Gioia S, Puzzono M, Bianchini M, Ridola L, Aprile F, Gitto S, Pelle G, Di Martino M, Marzocchi G, Caporali C, Spagnoli A, Di Rocco A, Schepis F. Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis. Radiology 2021;299:133-40. [PMID: 33529134 DOI: 10.1148/radiol.2021203051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Italian Association for the Study of the Liver (AISF). Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2021;53:1089-104. [PMID: 34321192 DOI: 10.1016/j.dld.2021.06.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Vidal-González J, Quiroga S, Simón-Talero M, Genescà J. Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem. Therap Adv Gastroenterol 2020;13:1756284820961287. [PMID: 33062057 DOI: 10.1177/1756284820961287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
52 Paternostro R, Reiberger T, Bucsics T. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease. World J Gastroenterol 2019; 25(3): 308-329 [PMID: 30686900 DOI: 10.3748/wjg.v25.i3.308] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
53 Montanha MC, Cottura N, Booth M, Hodge D, Bunglawala F, Kinvig H, Grañana-castillo S, Lloyd A, Khoo S, Siccardi M. PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease. Front Pharmacol 2022;13:814134. [DOI: 10.3389/fphar.2022.814134] [Reference Citation Analysis]
54 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., Clinical Practice Guideline Panel., Chair:., EASL Governing Board representative:., Panel members:. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol 2021;75:659-89. [PMID: 34166721 DOI: 10.1016/j.jhep.2021.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
55 He C, Lv Y, Wang Z, Guo W, Tie J, Li K, Niu J, Zuo L, Yu T, Yuan X, Chen H, Wang Q, Liu H, Bai W, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Wang J, Yin Z, Fan D, Han G. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis. Digestive and Liver Disease 2018;50:1315-23. [DOI: 10.1016/j.dld.2018.05.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
56 Bastati N, Beer L, Ba-Ssalamah A, Poetter-Lang S, Ambros R, Kristic A, Lauber D, Pomej K, Binter T, Simbrunner B, Semmler G, Balcar L, Bican Y, Hodge JC, Wrba T, Trauner M, Reiberger T, Mandorfer M. Gadoxetic Acid-enhanced MRI-derived Functional Liver Imaging Score (FLIS) and Spleen Diameter Predict Outcomes in ACLD. J Hepatol 2022:S0168-8278(22)00268-9. [PMID: 35525337 DOI: 10.1016/j.jhep.2022.04.032] [Reference Citation Analysis]
57 Praktiknjo M, Simón-talero M, Römer J, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-gonzález J, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, López M, Jansen C, Chang J, Schierwagen R, Uschner F, Kukuk G, Meyer C, Thomas D, Wolter K, Strassburg CP, Laleman W, La Mura V, Ripoll C, Berzigotti A, Calleja JL, Tandon P, Hernandez-gea V, Reiberger T, Albillos A, Tsochatzis EA, Krag A, Genescà J, Trebicka J, Quiroga S, Yu D, Téllez L, Mandorfer M, Garcia-pagan JC, Berbel C, Ferrusquia J, Ble M, Garcia-criado MA, Belmonte E, Ney M, Margini C, Casu S, Murgia G, Ludwig C, Stangl F. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. Journal of Hepatology 2020;72:1140-50. [DOI: 10.1016/j.jhep.2019.12.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
58 Wolter K, Praktiknjo M, Boie J, Decker G, Nadal J, Jansen C, Keller WIY, Meyer C, Trebicka J, Attenberger U, Thomas D. Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study. Cardiovasc Intervent Radiol 2021;44:1240-50. [PMID: 34021379 DOI: 10.1007/s00270-021-02852-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Leng X, Zhang F, Zhang M, Guo H, Yin X, Xiao J, Wang Y, Zou X, Zhuge Y. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt. Eur J Gastroenterol Hepatol 2019;31:853-8. [PMID: 30633039 DOI: 10.1097/MEG.0000000000001349] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
60 Elmahdy AM, Berzigotti A. Non-invasive Measurement of Portal Pressure. Curr Hepatology Rep 2019;18:20-7. [DOI: 10.1007/s11901-019-00446-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Lim WX, Lin AN, Cheng YF, Lee SY, Hsu HW, Chen CL, Chang WC, Yu CY, Tsang LL, Chuang YH, Ou HY. Portosystemic Shunt in Pediatric Living Donor Liver Transplant. Transplant Proc 2022:S0041-1345(21)00910-6. [PMID: 35022136 DOI: 10.1016/j.transproceed.2021.09.072] [Reference Citation Analysis]
62 Thevenot T, Weil D, Di Martino V. What Is the True Relationship Between Spontaneous Portosystemic Shunts and Portopulmonary Hypertension in Cirrhotic Patients? Gastroenterology 2018;155:1647-8. [PMID: 30118742 DOI: 10.1053/j.gastro.2018.02.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Kennedy P, Bane O, Hectors SJ, Fischman A, Schiano T, Lewis S, Taouli B. Noninvasive imaging assessment of portal hypertension. Abdom Radiol 2020;45:3473-95. [DOI: 10.1007/s00261-020-02729-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Maruyama H, Shiina S. Collaterals in portal hypertension: anatomy and clinical relevance. Quant Imaging Med Surg 2021;11:3867-81. [PMID: 34341755 DOI: 10.21037/qims-20-1328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Nardelli S, Gioia S, Ridola L, Riggio O. Radiological Intervention for Shunt Related Encephalopathy. J Clin Exp Hepatol 2018;8:452-9. [PMID: 30564003 DOI: 10.1016/j.jceh.2018.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
66 Than NN, Cataluna JG, Majumdar A. Acute Confusion Following Liver Transplantation: HE or Not HE, That Is the Question. Hepatology 2021;73:858-60. [PMID: 32627841 DOI: 10.1002/hep.31452] [Reference Citation Analysis]
67 Nicoară-Farcău O, Wang X, Luo X. Definition of SPSS: we need to speak the same language. J Hepatol 2020;73:463-4. [PMID: 32448470 DOI: 10.1016/j.jhep.2020.03.012] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 El-Khateeb E, Darwich AS, Achour B, Athwal V, Rostami-Hodjegan A. Review article: time to revisit Child-Pugh score as the basis for predicting drug clearance in hepatic impairment. Aliment Pharmacol Ther 2021;54:388-401. [PMID: 34218453 DOI: 10.1111/apt.16489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Ueno W, Sato N, Miura K, Morimoto N, Watanabe S, Nomoto H, Isoda N, Kijima S, Kikuchi T, Manaka S, Mori H, Yamamoto H. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis. Clin J Gastroenterol 2021;14:1227-32. [PMID: 33993428 DOI: 10.1007/s12328-021-01441-3] [Reference Citation Analysis]
70 Kim HW, Kim Y, Chae HB. Effective transvenous obliteration for portosystemic encephalopathy in a patient with liver cirrhosis and traumatic subarachnoid hemorrhage. Dig Liver Dis 2020:S1590-8658(20)30916-6. [PMID: 33051161 DOI: 10.1016/j.dld.2020.09.017] [Reference Citation Analysis]
71 Simón-Talero M, Genescà J. Reply. Gastroenterology 2018;155:1650-1. [PMID: 30315774 DOI: 10.1053/j.gastro.2018.10.021] [Reference Citation Analysis]
72 Trebicka J, Gu W, de Ledinghen V, Aubé C, Krag A, Praktiknjo M, Castera L, Dumortier J, Bauer DJM, Friedrich-Rust M, Pol S, Grgurevic I, Zheng R, Francque S, Gottfriedovà H, Mustapic S, Sporea I, Berzigotti A, Uschner FE, Simbrunner B, Ronot M, Cassinotto C, Kjaergaard M, Andrade F, Schulz M, Semmler G, Drinkovic IT, Chang J, Brol MJ, Rautou PE, Vanwolleghem T, Strassburg CP, Boursier J, Ferstl PG, Rasmussen DN, Reiberger T, Vilgrain V, Guibal A, Guillaud O, Zeuzem S, Vassord C, Lu X, Vonghia L, Senkerikova R, Popescu A, Margini C, Wang W, Thiele M, Jansen C. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut 2021:gutjnl-2020-323419. [PMID: 33479052 DOI: 10.1136/gutjnl-2020-323419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Piano S, Angeli P. Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation? Clin Liver Dis 2021;25:357-72. [PMID: 33838855 DOI: 10.1016/j.cld.2021.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Jindal A, Sarin SK, Kumar M, Kumar G. Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient ≤ 10 mm Hg. Dig Dis Sci 2022. [PMID: 35113276 DOI: 10.1007/s10620-021-07334-2] [Reference Citation Analysis]